Publication Name	World Journal of Gastroenterology
Manuscript ID	11300
Country	Spain

Received	2014-05-14 08:32
Peer-Review Started	2014-05-14 20:22
To Make the First Decision	2014-06-27 17:42
Return for Revision	2014-07-03 09:27
Revised	2014-08-27 00:00
Second Decision	2014-10-15 07:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-10-15 08:05
Articles in Press	2014-10-15 08:23
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-10-18 04:25
Typeset the Manuscript	2014-11-16 20:07
Publish the Manuscript Online	2014-12-02 10:46

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Management of recurrent hepatitis C virus after liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Miguel Jiménez-Pérez, Rocío González-Grande and Francisco Javier Rando-Muñoz
Funding Agency and Grant Number
Corresponding Author	Miguel Jiménez-Pérez, MD, Liver transplantation and hepatology unit, UGC de Aparato Digestivo, Unidad de Hepatología-Trasplante Hepático, Hospital Regional Universitario de Málaga, Avda Carlos Haya, 29010 Malaga, Spain. miguel.jimenez.sspa@juntadeandalucia.es
Key Words	Hepatitis C virus; Liver transplantation; Recurrence; Treatment
Core Tip	Chronic hepatitis C virus (HCV) infection is the reason for about 50% of liver transplants in the western world. Reinfection of the graft is universal and can compromise graft function and patient survival. The development of an efficient antiviral therapeutic strategy has been the focus of clinical research in recent years, including when, how much and at what point this treatment should be applied. The introduction of new drugs for the treatment of chronic HCV hepatitis may involve therapeutic changes and, perhaps, a better prognosis for these patients, particularly those with severe recurrence or factors predicting rapid progression of fibrosis.
Publish Date	2014-12-02 10:46
Citation	Jiménez-Pérez M, González-Grande R, Rando-Muñoz FJ. Management of recurrent hepatitis C virus after liver transplantation. World J Gastroenterol 2014; 20(44): 16409-16417
URL	http://www.wjgnet.com/1007-9327/full/v20/i44/16409.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i44.16409

Full Article (PDF)	WJG-20-16409.pdf
Full Article (Word)	WJG-20-16409.doc
Manuscript File	11300-Review.doc
Answering Reviewers	11300-Answering reviewers.pdf
Copyright License Agreement	11300-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	11300-Language certificate.pdf
Peer-review Report	11300-Peer review(s).pdf
Scientific Misconduct Check	11300-CrossCheck.jpg
Scientific Editor Work List	11300-Scientific editor work list.pdf